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SUMMARY 
Antioxidants inhibit the fatty acid oxygenase of sheep vesicular gland and 
soybean lipoxygenase in an ins~~n~us, reversible manner. Their in~bito~ ef- 
fectiveness was not related to their traditional antioxidant potencies but seemed to 
depend on the nature of the enzyme. The destructive effect of eicosa-58, I I, +tetray- 
noic acid, a substrate analog, on vesicular gland oxygenase could be prevented in the 
presence of either a-naphthol or 2,z,4-t~m~hyl-~ethox~I,2~ihydroquino~ne (San- 
toquin). 
Varied results have been reported for the effect of several antioxidants on 
prostaglandin formation. Hydroquinone (0, r-o.5 mM)l -6 and propyl gallate (0.3-0.5 
mM)’ s2 stimulated the production of pros~~~din but definite in~bition was ob- 
served at greater concentrations. Ascorbic acid2s5*’ and pyrrogallo12*4 were less ef- 
fective in increasing the yield of prostaglandin whereas the process was inhibited by 
cr-tocopherol(o.3-r mM)l. No inhibition was reported for 2,6-di-terz-butyl+hydro- 
xytoluene at 0.25 mM8. In our contin~ng investigations of the fatty acid oxygenase 
of sheep vesicular gland, an enzymic component of the prostaglandin biosynthetic 
pathway’, we have studied the effect of antioxidants on the oxygenase in order to 
further elucidate the mechanism of the initial oxygenation process’**‘l. 
MATERIALS AND METHODS 
0, absorption me~urem~ts were carried out on an automatic multisample contin- 
uous recording oxygen electrode system” with a 3-ml assay mixture containing 
0.1 M Tris-HCl (pH 8.5) buffer, 0.67 mM phenol, 4-40 PM arachidonic acid (Hor- 
me1 Institute), activated vesicular gland oxygenase (2 mg)l” and various concentra- 
tions of antioxi~nts (purchased from commercial sources). In some experiments, 
soybean lipoxygenase was substituted for the above enzyme with concomitant dele- 
tion of phenol. In other experiments, eicosa-5,8,11,14-tetraynoic acid (a gift from 
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Hoffmann-La Roche) and antioxidant were incubated together with vesicular gland 
oxygenase prior to the addition of arachidonic acid. 
RESULTS AND DISCUSSION 
A variety of antioxidants were found to inhibit the vesicular gland oxygenase 
(Table I) at much lower levels than previously reported’- *, but none of those tested 
exhibited an additional stimulating effect on the enzyme. Dixon plots” for the data 
indicated that the antioxidants could be subdivided into either competitive or non- 
competitive inhibitors. The curvature of some plots made the assignment of the nature 
of the inhibition difficult to determine, and the Ki values assigned to competitive in- 
hibitors may vary by a factor of 2-6. The competitive Ki values from these plots are 
consistently lower than the corresponding [Zj5,,* values determined at 12 PM 
arachidonic acid although the noncompetitive Ki values agree well with their com- 
parative [I],, values. This is expected since more than the theoretical half saturating 
amount of competitive inhibitor will be required in the presence of substrate to 
TABLE I 
INHIBITORY AND OTHER CHARACrERISTICS OF ANTIOXIDANTS 
The K, and [& were obtained as described in the text. The values were derived from at least eight 
determinations. C, competitive inhibitor, N.C., noncompetitive inhibitor. Relative efficiency of the 
antioxidant is measured by the time in which 20% carotene decomposed in mineral oil at 75 “C. 

























37 (N.C.) 56 
55 (C) 180 
100 (N.C.) 90 
200 (N.C.) 190 
400 (N.C.) 310 









0.68 (ref. 13), 0.933 (ref. 14) I54 
0.782 (ref. 15) 208 
0.64, 0.65 (ref. 13), 1.18 (ref. 15) 130 
6 
0.70 (ref. I3), I.153 (ref. 14) 
0.760 (ref. 15) 
18 
165** 
0.528 (ref. 14) 
0.56 (PH < 7), I.23 (PH > 7) 
(ref. 13) 0.715 (ref. 14) 8 
0.57, 0.68 (ref. 13) 
0.40 (ref. 15) 
0.754 (ref. 15) 
I42 
Citric acid, Na+ > 1700 > I700 
Pyrrogallol N.M.* N.M.* 0.28 (pH> 7), 0.51 OIH < 7) 
(ref. 13), 0.676 (ref. 14) I55 
* Not measurable because of unusual curvature. 
** Ethyl gallate instead of propyl gallate. 
Abbreviations: BHA, 2- and 3-rerr-butylhydroxyanisole; BHT, 2,6-di-rert-butyl-4-hydroxy- 
toluene; NDGA, nordihydroguaiaretic acid; Santoquin, 2,2,4-trimethyl-6-ethoxy-r,z-dihydroqui- 
noline; C, competitive inhibitor; NC., noncompetitive inhibitor. 
* [&,, is the concentration of inhibitor that causes 50 ‘A inhibition. 
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TABLE II 
COMPARATIVE ANTIOXIDANT INHIBITION OF VESICULAR GLAND OXYGENASE 


























Abbreviations: see Tabie I. 
reduce the velocity to 50%. All of the antioxidants tested behaved as instantaneous 
concentration-dependent inhibitors but none showed appreciable time-dependent in- 
hibition of/the oxygenase activity”. 
To determine whether these antioxidants exhibited similar effects on soybean 
lipoxygenase, three competitive and three non-competitive inhibitors were tested 
(Table II). Two from each category were found to be more effective with lipoxy- 
genase whereas 2,6-di-tert-butyi-4-hydroxytoluene and Santoquin (z,z,@imethyl- 
6-ethoxy-I,z-dihydroquinoline) were much less so. An early report by Tappel et aLI 
indicated that the relative inhibitory effectiveness of several antioxidants with soy- 
bean lipoxygenase was in the following order: nordihydroguaiaretic acid > propyl 
gallate > catechol CG hydroquinone z a-naphthol E a-tocopherol. These differences 
were much smaller than those that we are describing for the vesicular gland oxygenase. 
Apparently the inhibitory ability of these agents is influenced by the nature of the 
TABLE III 
a-NAPHTHOL AND SANTOQUIN PREVENT DESTRUCTIVE ACTION OF EICOSA-5,8,1 I, 
14-TETRAYNOIC ACID ON VESICULAR GLAND OXYGENASE 
Phenol-activated oxygenase (2 mg) was added to an assay mixture containing 0.66 mM phenol, 
6 PM eicosa-5,&I 1,x4-tetraynoic acid and the indicated concentrations of either a-naphthol or 
Santoquin at 30 “C. After incubating for t min, arachidonic acid (25 pM) was added and O2 absorp- 
tion measurements were carried out as previously reported ll. The decreased activity (‘A) is calcu- 
lated as IOO (I - v/vo) where v = initial rate (pmoles/min) after t min preincubation and v. = initial 
rate without preincubation. 
a-Naphthol Santoquin 
(PM) (PM) 
Decreased activity ( %) 
Preincubation time: 
I min 8 min 
0 I7 65 
2.2 7 46 
4.4 3 22 
‘3.35 3 18 
2 II 61 
4 I 46 
9.25 I 8 
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enzyme and not solely related to their traditional antioxidant potencies (some of 
which are listed in Table I). 
We recently reported that eicosa-5,8,1 r,r+tetraynoic acid inhibited vesicular 
gland oxygenase in an instantaneous, concentration-dependent manner in addition to 
causing a time-dependent destruction of the enzyme”. When the enzyme was in- 
cubated with this acetylenic acid and either cr-naphthol or Santoquin, the lowered 
velocity observed at zero incubation time could be accounted for by the additive 
effects of the acetylenic acid and the antioxidant. However, the time-dependent de- 
structive action of the tetrayne was prevented (Table III). From these results, it appears 
that a-naphthol and Santoquin are inhibiting in a different manner than eicosate- 
traynoic acid which seems to function as a substrate analog. 
Our results suggest that a careful evaluation of the effects of dietary antioxi- 
dants may show a diminution in prostaglandin synthesis similar to that seen with 
non-steroidal anti-inflammatory agents . ‘* In regard to suggestions that antioxidants 
may be used to retard the aging process’9*20, we wonder whether this retardation is 
dependent upon the inhibition of prostaglandin synthesis or occurs in spite of the 
inhibition. 
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